Quick Answer: Retatrutide has no current US price because it isnt FDA approved as of May 2026 Tirzepatide pen prices when introduced: Mounjaro (T2D label): ,069.08 per month list Zepbound (obesity label): ,059.87 per month list Lilly priced both tirzepatide formulations to undercut Wegovy (semaglutide 2.4 mg at ,349 list) by about 20 percent
Mounjaro may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, worsening of diabetic retinopathy if you have type 2 diabetes
Caplan for truly caring
a , Scatter plot of current crystallized ligands
At the 3-month mark, participants in the WW program lost an average of 3.8 kilograms (kg), compared to 1.8 kg in the DIY group
The rise in popularity of GLP-1 medications like Ozempic and Wegovy has been driven by their dramatic weight loss results